Yvonne Greenstreet, Alnylam CEO (Suzanne Kreiter/The Boston Globe via Getty Images)
March 9, 2023 03:02 PM EST
Pharma
Marketing

Al­ny­lam ex­pands RNAi com­mer­cial­iza­tion deal in Eu­rope

Nicole DeFeudis

Editor

Al­ny­lam is dou­bling down on a part­ner­ship to ex­pand its com­mer­cial pres­ence in Eu­rope, as it forges ahead on for­mer CEO John Maraganore’s mis­sion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times